Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

More from SmithKline Beecham on p38 MAP kinase inhibitors

Feb. 18, 1999

Antiarthritic effects, mechanism and GI safety of S-2474 evaluated in rat model

Feb. 17, 1999

Vertex patents new series with strong and specific p38 kinase-inhibitory activity

Feb. 17, 1999

Phase III trial data support leflunomide as useful RA treatment option

Feb. 16, 1999

IL-1beta inhibitors from ADIR useful for inflammatory conditions

Feb. 16, 1999

Imidazole cytokine-suppressive antiinflammatory compounds from SB

Feb. 16, 1999

Mechanism of action of T-614 in RA examined in vitro

Feb. 15, 1999

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

Celebrex receives approval in Mexico

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...